153 related articles for article (PubMed ID: 31180526)
21. Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation.
Xiao Y; Ma W; Hu W; Di Q; Zhao X; Ma X; Chen X; Sun P; Wu H; Wu Z; Chen W
Mol Oncol; 2022 Jan; 16(2):388-404. PubMed ID: 33811456
[TBL] [Abstract][Full Text] [Related]
22. Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3/TAX ovarian cancer cells.
Jiang YP; Guo H; Wang XB
Biomed Pharmacother; 2018 Jul; 103():29-37. PubMed ID: 29635125
[TBL] [Abstract][Full Text] [Related]
23. USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2.
Wu J; Chen Y; Geng G; Li L; Yin P; Nowsheen S; Li Y; Wu C; Liu J; Zhao F; Kim W; Zhou Q; Huang J; Guo G; Zhang C; Tu X; Gao X; Lou Z; Luo K; Qiao H; Yuan J
Cancer Lett; 2019 May; 449():114-124. PubMed ID: 30771428
[TBL] [Abstract][Full Text] [Related]
24. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.
Gao M; Ma Y; Bast RC; Li Y; Wan L; Liu Y; Sun Y; Fang Z; Zhang L; Wang X; Wei Z
Med Oncol; 2016 Jul; 33(7):73. PubMed ID: 27277757
[TBL] [Abstract][Full Text] [Related]
25. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
26. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
27. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
28. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.
Wang H; Zhu L; Gao J; Hu Z; Lin B
Oncol Rep; 2015 Jan; 33(1):403-12. PubMed ID: 25354091
[TBL] [Abstract][Full Text] [Related]
29. An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics.
Nilsson EE; Westfall SD; McDonald C; Lison T; Sadler-Riggleman I; Skinner MK
Cancer Chemother Pharmacol; 2002 Feb; 49(2):93-100. PubMed ID: 11862422
[TBL] [Abstract][Full Text] [Related]
30. USP39 Serves as a Deubiquitinase to Stabilize STAT1 and Sustains Type I IFN-Induced Antiviral Immunity.
Peng Y; Guo J; Sun T; Fu Y; Zheng H; Dong C; Xiong S
J Immunol; 2020 Dec; 205(11):3167-3178. PubMed ID: 33127822
[TBL] [Abstract][Full Text] [Related]
31. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
32. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.
Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248
[TBL] [Abstract][Full Text] [Related]
33. HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC).
Lopes-Coelho F; Gouveia-Fernandes S; Gonçalves LG; Nunes C; Faustino I; Silva F; Félix A; Pereira SA; Serpa J
Tumour Biol; 2016 Apr; 37(4):4813-29. PubMed ID: 26520442
[TBL] [Abstract][Full Text] [Related]
34. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
[TBL] [Abstract][Full Text] [Related]
35. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
36. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
[TBL] [Abstract][Full Text] [Related]
37. USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression.
Xiao Y; Chen X; Hu W; Ma W; Di Q; Tang H; Zhao X; Huang G; Chen W
Transl Oncol; 2023 Aug; 34():101713. PubMed ID: 37302347
[TBL] [Abstract][Full Text] [Related]
38. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Ca
Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
[TBL] [Abstract][Full Text] [Related]
40. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
